mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.084 |
0.03 |
mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.03 |
mRNA |
BRD-K34222889 |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.04 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
16-beta-bromoandrosterone |
CTRPv2 |
pan-cancer |
AAC |
0.081 |
0.04 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
AZD6482 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.04 |
mRNA |
ML311 |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |